Evidence map›Paper›PMID 39724015›Full record

ArticleJCI insight2024

Endothelial response to blood-brain barrier disruption in the human brain.

Andrew Gould, Yu Luan, Ye Hou, Farida V Korobova, Li Chen, Victor A Arrieta, Christina Amidei, Rachel Ward, Cristal Gomez, Brandyn Castro and 11 more

Registry-linked trialAbstract readClinical Trial, Phase I
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04528680 (Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment With Albumin-bound Paclitaxel and Carboplatin in Patients With Recurrent Glioblastoma), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04528680 phase1 / phase2active not recruitingnot on this map

Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment With Albumin-bound Paclitaxel and Carboplatin in Patients With Recurrent Glioblastoma

TypeinterventionalSponsorNorthwestern UniversityRan2020 to 2026Enrolled57ConditionsGlioblastoma, Gliosarcoma, GBM, Glioblastoma MultiformeArmsSonication for opening of blood-brain barrier, Chemotherapy, albumin-bound paclitaxel, Chemotherapy, carboplatin
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Pharmacokinetic Analysis of Carboplatin and Fluorescein Brain Retention following Ultrasound-Based Blood-Brain Barrier Opening.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Trial
  3. Review
  4. Caveolae mechanics in cellular functions and disease.Nature reviews. Molecular cell biology · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Mouse Models of Food Allergies: Where Do They Take Us?Clinical reviews in allergy & immunology · 2026
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Andrew GouldDepartment of Neurological Surgery.
Yu LuanDepartment of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Ye HouInstitute of Biomedicine, College of Life Sciences, Inner Mongolia University, Hohhot, China.
Farida V KorobovaDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Li ChenDepartment of Neurological Surgery.
Victor A ArrietaDepartment of Neurological Surgery.
Christina AmideiDepartment of Neurological Surgery.
Rachel WardDepartment of Neurological Surgery.
Cristal GomezDepartment of Neurological Surgery.
Brandyn CastroDepartment of Neurological Surgery.
Karl HabashyDepartment of Neurological Surgery.
Daniel ZhangDepartment of Neurological Surgery.
Mark YoungbloodDepartment of Neurological Surgery.
Crismita DmelloDepartment of Neurological Surgery.
John BebawyDepartment of Neurological Surgery.
Guillaume BouchouxCarthera, Lyon, France.
Roger StuppDepartment of Neurological Surgery.
Michael CanneyCarthera, Lyon, France.
Feng YueNorthwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, and.
M Luisa Iruela-ArispeDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Adam M SonabendDepartment of Neurological Surgery.

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Devalingam Mahalingam · 1993 to 2026
$153.9M
STINGing GBM: A First-in- Man Clinical Trial in Surgical Resectable Recurrent GBMP50CA221747 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Hui Zhang · 2018 to 2026
$21.4M
Leveraging doxorubicin immune-modulation, blood-brain barrier opening, and personalized medicine for effective immunotherapy in glioblastoma. A mechanistic approach and pharmacokinetic trial.U19CA264338 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Adam M Sonabend · 2021 to 2026
$5.8M
Blood-brain barrier disruption with implantable ultrasound to enhance paclitaxel delivery: A Phase 1-2 clinical trial in recurrent glioblastomaR01CA245969 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Adam M Sonabend, Roger Stupp · 2020 to 2026
$2.8M
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapyR01NS110703 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SONABEND, ADAM M · 2020 to 2024
$1.9M
NCI NIH HHS P30 CA060553NCI NIH HHS P50 CA221747NCI NIH HHS R01 CA245969NCI NIH HHS U19 CA264338NINDS NIH HHS R01 NS110703
6 · The paper itself

Abstract

Cerebral endothelial cell (EC) injury and blood-brain barrier (BBB) permeability contribute to neuronal injury in acute neurological disease states. Preclinical experiments have used animal models to study this phenomenon, yet the response of human cerebral ECs to BBB disruption remains unclear. In our phase I clinical trial (ClinicalTrials.gov NCT04528680), we used low-intensity pulsed ultrasound with microbubbles (LIPU/MB) to induce transient BBB disruption of peritumoral brain in patients with recurrent glioblastoma. We found radiographic evidence that BBB integrity was mostly restored within 1 hour of this procedure. Using single-cell RNA sequencing and transmission electron microscopy, we analyzed the acute response of human brain ECs to ultrasound-mediated BBB disruption. Our analysis revealed distinct EC gene expression changes after LIPU/MB, particularly in genes related to neurovascular barrier function and structure, including changes to genes involved in the basement membrane, EC cytoskeleton, and junction complexes, as well as caveolar transcytosis and various solute transporters. Ultrastructural analysis showed that LIPU/MB led to a decrease in luminal caveolae, the emergence of cytoplasmic vacuoles, and the disruption of the basement membrane and tight junctions, among other things. These findings suggested that acute BBB disruption by LIPU/MB led to specific transcriptional and ultrastructural changes and could represent a conserved mechanism of BBB repair after neurovascular injury in humans.

Indexed as

Blood-Brain BarrierBrainBrain NeoplasmsEndothelial CellsGlioblastomaFemaleHumansMaleMicrobubblesMiddle AgedTight JunctionsUltrasonic WavesEndothelial cellsNeuroscienceVascular biology

Identifiers

PMID39724015
PMCPMC11949064

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.